FindTrial
Sign In

Proportion of Chronic kidney disease children and adolescents with lipid profile abnormalities

Prevalence of dyslipidemia in children and adolescence with chronic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025072
Enrollment
75
Registered
2020-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Sponsors

Department of pediatrics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children aged between 2- 18 years with chronic kidney disease

Exclusion criteria

Exclusion criteria: Children and adolescents already on lipid lowering drugs , overweight , or obese children , known cases of diabetes mellitus , hypothyroidism or on steroid therapy will be excluded from study

Design outcomes

Primary

MeasureTime frame
To determine the levels of triglycerides , high density lipoproteins , low density lipoproteins , apolipoprotein A-1, apolipoprotein B, in children and adolescents with chronic kidney diseaseTimepoint: 12 months study durtaion—

Secondary

MeasureTime frame
To look for relationship of dyslipidemia with age , stage , cause and duration of chronic kidney diseaseTimepoint: 12 months of study duration—

Countries

India

Contacts

Public ContactAkshay kumar M

Maulana Azad medical college and associated loknayak hospital

muktamantan@hotmail.com9968604315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026